Atorvaliq Drug Interactions: 46 Major, 464 Moderate
Atorvaliq Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Atorvaliq. Always confirm against the full prescribing information.
100 interactions
Abacavir
Abacavir may increase the hepatotoxic activities of Atorvastatin.
Level 2 evidence
Abatacept
The metabolism of Atorvastatin can be increased when combined with Abatacept.
Level 1 evidence
Abiraterone
The metabolism of Atorvastatin can be decreased when combined with Abiraterone.
Level 2 evidence
Acalabrutinib
The metabolism of Atorvastatin can be decreased when combined with Acalabrutinib.
Level 1 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Atorvastatin.
Level 2 evidence
Acenocoumarol
The risk or severity of bleeding can be increased when Atorvastatin is combined with Acenocoumarol.
Level 2 evidence
Acetaminophen
The metabolism of Atorvastatin can be decreased when combined with Acetaminophen.
Level 1 evidence
Acetazolamide
The metabolism of Atorvastatin can be decreased when combined with Acetazolamide.
Level 1 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Atorvastatin.
Level 2 evidence
Adalimumab
The metabolism of Atorvastatin can be increased when combined with Adalimumab.
Level 1 evidence
Adenine
The metabolism of Atorvastatin can be decreased when combined with Adenine.
Level 2 evidence
Albendazole
Albendazole may increase the hepatotoxic activities of Atorvastatin.
Level 2 evidence
Enter your NPI to unlock 6 major interactions for Atorvaliq
Atorvaliq has 796 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Atorvaliq has 46 major, 464 moderate, and 286 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Atorvaliq. Always confirm against the full prescribing information.